Markus Loeffler
- Genetics top 0.05%
- Chronic Lymphocytic Leukemia Research 45
- Glioma Diagnosis and Treatment 28
- Pathology and Forensic Medicine top 0.05%
- Lymphoma Diagnosis and Treatment 91
- Oncology top 0.2%
- Cancer Cells and Metastasis 30
- Neurology top 0.5%
- CNS Lymphoma Diagnosis and Treatment 18
- Cancer Research top 0.5%
-
- Hematopoietic Stem Cell Transplantation 27
-
- Lung Cancer Treatments and Mutations 26
-
- Acute Lymphoblastic Leukemia research 22
- Co-authors
- C.S. PottenMichael PfreundschuhIngo RoederNorbert SchmitzChristoph EngelChristopher S. PottenMarita ZiepertDirk Hasenclever
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Markus Loeffler
383 papers receiving 18.2k citations
Hit Papers
Peers
Comparison fields: 5 of 202
- Genetics 4.2k
- Pathology and Forensic Medicine 5.6k
- Oncology 5.7k
- Neurology 2.3k
- Cancer Research 2.2k
Countries citing papers authored by Markus Loeffler
This map shows the geographic impact of Markus Loeffler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Loeffler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Loeffler more than expected).
Fields of papers citing papers by Markus Loeffler
This network shows the impact of papers produced by Markus Loeffler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Loeffler. The network helps show where Markus Loeffler may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Markus Loeffler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 3 | |
| 8 | 2020 | 9 | |
| 9 | 2020 | 13 | |
| 10 | 2017 | 27 | |
| 11 | 2016 | 11 | |
| 12 | 2013 | 173 | |
| 13 | 2013 | 138 | |
| 14 | 2010 | 377 | |
| 15 | 2009 | 194 | |
| 16 | 2009 | 476 | |
| 17 | Biased and unbiased clonal competition - Application of a new dynamical model of stem cell organization. | 2003 | 1 |
| 18 | SCF TREATMENT PREVENTS THE MUTUAL INHIBITION OF GRANULOPOIESIS AND ERYTHROPOIESIS, INDUCED BY EPO AND G-CSF | 1993 | 1 |
| 19 | THE MUTUAL INHIBITION OF ERYTHROPOIESIS AND GRANULOPOIESIS DURING G-CSF AND ERYTHROPOIETIN ADMINISTRATION | 1992 | 1 |
| 20 | A solution to the controversy on stem cell regulation. | 1982 | 4 |
About Markus Loeffler
Markus Loeffler is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 394 papers that have together received 18.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (91 papers), Chronic Lymphocytic Leukemia Research (45 papers), Cancer Cells and Metastasis (30 papers), Glioma Diagnosis and Treatment (28 papers), Hematopoietic Stem Cell Transplantation (27 papers), Lung Cancer Treatments and Mutations (26 papers), Acute Lymphoblastic Leukemia research (22 papers) and CNS Lymphoma Diagnosis and Treatment (18 papers). The work is most often cited by research in Genetics (4.2k citations), Pathology and Forensic Medicine (5.6k citations) and Oncology (5.7k citations). Markus Loeffler has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include C.S. Potten, Michael Pfreundschuh, Ingo Roeder, Norbert Schmitz, Christoph Engel, Christopher S. Potten, Marita Ziepert, Dirk Hasenclever, Markus Scholz and Volker Diehl. Their work appears in journals such as Journal of Clinical Oncology, Blood, Annals of Oncology, Cell Proliferation and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.